Endocrinology. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

By Beckers N.G.M.  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 43-49

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cycles

By Kol S.  

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2242-2244

Oxford University Press

Access to resources Recommend Favorite

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist

By Ragni Guido   Vegetti Walter   Baroni Elena   Colombo Michela   Arnoldi Mariangela   Lombroso Giancarlo  

Human Reproduction, Vol. 16, Iss. 11, 2001-11 ,pp. : 2258-2262

Oxford University Press

Access to resources Recommend Favorite

EndocrinologyHormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix)

By Albano C.  

Human Reproduction, Vol. 11, Iss. 10, 1996-10 ,pp. : 2114-2118

Oxford University Press

Access to resources Recommend Favorite